OX2 Therapeutics

About:

OX2 Therapeutics is a healthcare therapeutics company that focuses on treating brain tumors.

Website: https://ox2therapeutics.com

Description:

OX2 Therapeutics is a healthcare therapeutics company that focuses on treating brain tumors. Its novel CD200 Checkpoint peptide inhibitor activates the immune system through a CD200 activation receptor, enabling healthcare institutes to apply receptor antibodies that permit the immune system army to pass through blood vessel walls and kill cancer activities.

Total Funding Amount:

$649000

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Minneapolis, Minnesota, United States

Founded Date:

2016-06-01

Founders:

Christopher Moertel, Sumant Dhawan

Number of Employees:

1-10

Last Funding Date:

2020-09-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai